| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 940 |
| 1 | PYRIDOSTIGMINE BROMIDE | 878 |
| 2 | EFGARTIGIMOD ALFA | 785 |
| 3 | ECULIZUMAB | 574 |
| 4 | PEMBROLIZUMAB | 549 |
| 5 | RAVULIZUMAB | 511 |
| 6 | ACETAMINOPHEN | 486 |
| 7 | NIVOLUMAB | 485 |
| 8 | PYRIDOSTIGMINE BROMIDE ORAL | 437 |
| 9 | GABAPENTIN | 393 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMMONIUM CHLORIDE | 106 | 0.4240 |
| 1 | EFGARTIGIMOD ALFA | 785 | 0.1978 |
| 2 | CHLORAMPHENICOL SODIUM SUCCINATE | 5 | 0.1515 |
| 3 | ASIAN GINSENG | 60 | 0.1422 |
| 4 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 68 | 0.1402 |
| 5 | NATAMYCIN | 55 | 0.1341 |
| 6 | BISMUTH SUBGALLATE | 6 | 0.1304 |
| 7 | PYRIDOSTIGMINE BROMIDE ORAL | 437 | 0.1230 |
| 8 | PYRIDOSTIGMINE BROMIDE | 878 | 0.1151 |
| 9 | SODIUM CITRATE | 135 | 0.1075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1659 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1191 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1153 |
| 3 | Complement Inhibitor [EPC] | 1016 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 766 |
| 5 | Proton Pump Inhibitor [EPC] | 522 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 514 |
| 7 | Osmotic Laxative [EPC] | 379 |
| 8 | Vitamin C [EPC] | 367 |
| 9 | Insulin Analog [EPC] | 353 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 1191 | 0.2715 |
| 1 | Polyene Antimicrobial [EPC] | 55 | 0.1341 |
| 2 | Interleukin-5 Antagonist [EPC] | 50 | 0.0727 |
| 3 | Endoglycosidase [EPC] | 70 | 0.0378 |
| 4 | Osmotic Diuretic [EPC] | 140 | 0.0268 |
| 5 | Lymphocyte Activation Gene-3 Blocker [EPC] | 12 | 0.0233 |
| 6 | Vitamin K [EPC] | 192 | 0.0222 |
| 7 | Complement Inhibitor [EPC] | 1016 | 0.0181 |
| 8 | Bismuth [EPC] | 76 | 0.0136 |
| 9 | Human Immunoglobulin G [EPC] | 275 | 0.0131 |